Validation of Fimbristylis ovata for pharmaceutical Applications

Fimbristylis ovata is a medicinal plant traditionally used in various Ayurvedic and Unani systems for its therapeutic properties. Biometabolites are responsible for medicinal properties of a plant. In the present study, F. ovata underwent comprehensive phytochemical screening, qualitative estimation of secondary metabolites, assessment of antioxidant activity using the DPPH method, GC-MS analysis, and ICP-OES analyses. The results revealed the presence of various secondary metabolites, including phenols, flavonoids, tannins, and saponins. The antioxidant activity demonstrated a significant ability to scavenge free radicals. GC-MS analysis identified six compounds, including 1,2-Propanediamine and Cyclotrisiloxane-hexamethyl, which have notable medicinal and industrial applications. Furthermore, ICP-OES results showed the presence of essential elements such as calcium, zinc, and iron, all of which contribute to the plant's high antioxidant activity.These findings support the traditional use of F. ovata and provide a scientific basis for its potential applications in the pharmaceutical and nutraceutical industries.